<DOC>
	<DOCNO>NCT02879019</DOCNO>
	<brief_summary>Whereas efficacy exercise intervention abundantly prove male peripheral artery disease ( PAD ) , remain determined whether intervention effective woman . The aim randomize control trial perform 34 PAD woman investigate effect 12 week supervise walk functional capacity cardiovascular function regulation rest exercise .</brief_summary>
	<brief_title>Walking Training Peripheral Artery Disease ( GrEnADa Sub-study )</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>aanklebrachial index ( ABI ) â‰¤ 0.9 one two legs fontaine stage II PAD body mass index &lt; 35 kg/m2 rest systolic blood pressure ( BP ) &lt; 160 mmHg diastolic BP &lt; 105 mmHg ability walk least 2min 3.2 km/h ability undertake incremental treadmill test decrease least 15 % ABI maximal treadmill test currently engage regular exercise program exercise induce sign myocardial ischemia complex ventricular arrhythmia cardiovascular autonomic neuropathy use betablocker , nondihydropyridine calcium antagonist insulin hormone replacement therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>